Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
5/9
9/9
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 3 Months

13 Years 11 Months

Fund AUM

₹1103 Cr

₹9479 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹1000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.02%

0.99%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

40

38

Top 5 Holdings
  1. Torrent Pharmaceuticals Ltd(9.94%)
  2. Sun Pharmaceuticals Industries Ltd(9.75%)
  3. Apollo Hospitals Enterprise Ltd(7.08%)
  4. Cipla Ltd(4.56%)
  5. Aurobindo Pharma Ltd(4.29%)
  1. Sun Pharmaceuticals Industries Ltd(13.31%)
  2. Lupin Ltd(7.25%)
  3. Divi's Laboratories Ltd(6.52%)
  4. Cipla Ltd(6.03%)
  5. Apollo Hospitals Enterprise Ltd(5.3%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(99.2%)
  2. Basic Materials(0.8%)

Health

(100%)

Equity %

97.61%

97.32%

Debt %

-

-

P/E

40.73

39.2

P/B

6.33

5.82

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

0.07%

0.02%

3-Month Return

6.87%

4.21%

6-Month Return

19.65%

14.97%

1-Year Return

19.96%

13.71%

3-Year Return

22.27%

19.7%

5-Year Return

14.65%

14.01%

Sharpe

1.04

0.89

Alpha

1.17

-1.21

Beta

0.91

0.88

Standard Deviation

15.3

14.77

Information Ratio

-0.06

-0.88

Description

Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhaval Shah

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons